Subscribe to our Newsletters !!

    Kumar Jeetendra

    Dr. Reddy’s ascents after Hyderabad office gets EIR from USFDA

    Dr. Reddy’s Laboratories rose 0.71% to Rs 3725.7 after the organization said its definitions producing plant – 3 at Bachupally in Hyderabad got the foundation examination report (EIR) from US medicate controller. Dr. Reddy’s will report Q4 results today, 20 May 2020. The medication creator revealed a united total deficit of Rs 538.40 crore in

    Cipla receives final approval for generic version of Migranal®

    Mumbai, India; May 21, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (“ANDA”) for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the United States Food and Drug Administration (U.S. FDA) with a Competitive Generic Therapy (“CGT”)

    1000-overlay increment in quantum of COVID-19 tests: ICMR

    For each positive COVID-19 test in excess of 20 negative tests have been done, the ICMR has stated, attesting there has been a 1,000-crease increment in the quantum of tests every day over the most recent two months. An aggregate of 25,12,388 examples had been tried by 9 am of May 20, and the testing

    Strides Pharma to direct preliminaries in India for potential COVID-19 medication

    Indian pharmaceutical organization Strides Pharma Science Ltd said on Thursday it has acquired administrative endorsement to direct clinical preliminaries of antiviral medication favipiravir, a potential treatment for COVID-19. The organization has gotten endorsement from the Drug Controller General of India to direct preliminaries of favipiravir in the nation, Strides Founder and Non-Executive Chairman Arun Kumar

    AstraZeneca to make billion COVID antibody dosages if tests succeed

    AstraZeneca (AZN.L) hopes to have the option to convey a billion dosages of a potential COVID-19 immunization this year and next if tests are effective, including Thursday it ought to right away get aftereffects of a beginning time clinical path. The British drugmaker said it had consented to the main arrangements to flexibly at any

    Aerogen lowers the transmission risk of patient generated infectious aerosol

    Aerogen lowers the transmission risk of patient generated infectious aerosol as it sits above a closed circuit potentially reducing the risk of Healthcare Professional contamination from the circuit or patient1. Aerogen is the only closed-system high efficiency nebulizer that can be utilized for drug delivery with ventilators being used to treat COVID-19 patients. Aerogen Vibrating

    High-Throughput Screening using Luciferase Reporter Cell Lines

    AMSBIO reports on the positive customer feedback received for their One-Step Luciferase Assay kit recently introduced for quantitation of firefly luciferase activity in mammalian cell culture. Dr Maja Petkovic, Custom Services Business Unit Manager at AMSBIO said “Initial uptake of this new kit has been strong particularly for high throughput screening applications. Our customers have

    SARS-CoV-2 contamination analyzed by cell culture in 7-week-old Italian child

    A 7-week-old Italian child kid was determined to have SARS-CoV-2 contamination before the neighborhood episode by cell-culture segregation, as indicated by another case report. “Every single febrile child, regardless of whether momentarily febrile, ought to be researched for all respiratory infections, including SARS-CoV-2,” Dr. Adriana Calderaro of the University of Parma revealed to Reuters Health